News

The extraction service will complement the company’s existing capacity in Berlin, Germany and London, UK and will be delivered from the genomics laboratory in Beverly, Massachusetts , US.

The company anticipates making the hypertension medication, that is to be administered once a day, available to patients across Canada in the second quarter of 2013. Forest Laboratories

Both the companies plan to integrate the management of Daiichi Sankyo (Thailand) (DSTH) and Ranbaxy Unichem (RUCL), the Thailand subsidiary of Daiichi Sankyo and Ranbaxy’s Thailand subsidiary respectively.

The submissions for the approval are supported by risk stratification data and a risk algorithm, which enables physicians and patients with MS to make informed decisions when considering

The distinctive formulation of ondansetron was developed leveraging MonoSol Rx’s PharmFilm technology. Company relaunched Zuplenz, the first oral soluble lingual film product cleared by FDA as a prescription

Duchesnay executive vice-president Eric Gervais said, "We are excited to enable expectant mothers within the Israeli market to have access to a proven safe and effective pharmacological treatment

Astellas is seeking approval to use Tarceva as the first-line therapy to treat patients with EGFR activating mutation-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). The

Galapagos earns a milestone payment of EUR4m from Janssen for achieving the milestone of identifying a second pre-clinical candidate. According to the deal signed between the two companies

Company expects to complete the study within six to eight months and file for FDA clearance of APPY1 in the fourth quarter of 2013. Venaxis president and CEO